clopidogrel

Original Contribution

Toward Personalized DAPT: Is There an Inter-Manufacturer Difference in Generic Clopidogrel Response?

11/23/2022

Sylvie Hall, PharmD, MPH¹; Yuhe Xia, MS²; Hamza Ahmed, BA³;
Daniela Iskhakov, PA-C⁴; Frederick Feit, MD⁴; Carlos L. Alviar, MD⁴;
Jeffrey S. Berger, MD, MS⁴; Norma Keller, MD⁴; Sripal Bangalore, MD, MHA⁴

Sylvie Hall, PharmD, MPH1; Yuhe Xia,...

This quality-improvement project included 515 adult patients receiving clopidogrel for ACS or ischemic heart disease and referred for coronary angiography/percutaneous coronary intervention. The project was divided into 2 phases: (1)...

This quality-improvement project...

11/23/2022

Journal of Invasive Cardiology

Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry

07/14/2019

Sorin J. Brener, MD; Venkatesh Alapati, MD; Max M. Benson, MD; Doris Chan, DO; Gregory Cunn, MD; Saadat Khan, MD; Issa Kutkut, MD; C. Arun Narayanan, MD; John P. O’Laughlin, MD; Terrence J. Sacchi, MD

Sorin J. Brener, MD; Venkatesh Alapa...

We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.

We identified ACS patients from...

07/14/2019

Journal of Invasive Cardiology

Original Contribution

Safety of Percutaneous Coronary Intervention Without P2Y12 Inhibitor Pretreatment From a Cohort of Unselected Patients

07/15/2018

Benoit Lattuca, MD¹; David Belardi, MD¹; Christophe Demattei, MD²; Laurent Schmutz, MD¹; Luc Cornillet, MD¹; Bertrand Ledermann, MD¹; Jean-Christophe Macia, MD³; Ana√Øs Iemmi, MD³; Richard Gervasoni, MD³; Fran√ßois Roubille, MD, PhD³; Thien Tri Cung, MD³; Pierre Robert, MD³; Patrick Messner-Pellenc, MD, PhD¹; Florence Leclercq, MD, PhD³; Guillaume Cayla, MD, PhD¹

Benoit Lattuca, MD1; David Belardi, ...

Recent studies have challenged systematic pretreatment with a P2Y12 inhibitor before PCI in elective and NSTEMI patients. This study assesses outcomes after performing PCI immediately after coronary angiography with an exclusive...

Recent studies have challenged...

07/15/2018

Journal of Invasive Cardiology

Letters to the Editor

Prehospital Clopidogrel Administration in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary PCI: Real-Life Experience From the Multicenter NRDES Registry

05/27/2016

Tomasz Rakowski, MD, PhD¹; Zbigniew Siudak, MD, PhD¹; Artur Dziewierz, MD, PhD¹; Agata Sawina, MD¹; Dariusz Dudek, MD, PhD²

Tomasz Rakowski, MD, PhD1; Zbigniew ...

We sought to compare outcomes of STEMI patients from the National Registry of Drug-Eluting Stents (NRDES) stratified by time of clopidogrel loading dose administration.

We sought to compare outcomes of...

05/27/2016

Journal of Invasive Cardiology

Delayed Clopidogrel Transit During Myocardial Infarction Evident on Angiography

04/29/2015

Joanna Ghobrial, MD, MS; C. Michael Gibson, MS, MD; Duane S. Pinto, MD, MPH

Joanna Ghobrial, MD, MS; C. Michael ...

We describe the case of a patient with NSTEMI where oral clopidogrel loading prior to PCI was directly visualized on angiography, implying a very low likelihood of adequate absorption or antiplatelet effect. This observation raises the...

We describe the case of a...

04/29/2015

Journal of Invasive Cardiology